Universal Market Study on Hospital Acquired Infections (HAIs) Control


Posted May 25, 2015 by pramodsing4

MRRSE.Com Announces addition of new report"Hospital Acquired Infections (HAIs) Control"to its database

 
Albany, New York, 29 April, 2015 : Market Research Reports Search Engine (MRRSE), has announced that it now carries a report titled ‘Global Market Study on HAIs Control Market: Cleaning and Sterilization to Witness Highest Growth by 2020’. The need to control hospital acquired infections (HAIs) has escalated into a massive market, which approximated US$50,807.0 million in 2014. The findings of the report, published by Market Research Report Search Engine (MRRSE) , show that the market for HAIs control will soar to US$82,889.4 million by the end of 2020. The estimated CAGR for the HAIs control market is pegged at 8.5% between 2014 and 2020.
Besides these forecasts, the report also lays down the various factors working against the HAIs control market. These include an absence of the right infrastructure and primary healthcare facilities. There is a pressing need for well-trained staff to manage hospital acquired infections, which if left unaddressed, could dent the market further.

Browse Full Report with TOC - http://www.mrrse.com/hospital-acquired-infection-control-market
The team of analysts that worked on this report finds that in the global context, the HAIs control market will grow considerably because the occurrence of hospital acquired infections has risen. Moreover, as the number of aged people—an age group that’s especially vulnerable to infections—rises, analysts expect to see a parallel rise in the number of older people suffering from HAIs. The problem of hospital acquired infections is especially serious in regions with a tropical climate, which will understandably prompt more investments in HAI control. The HAIs control market is also impelled by governments taking an added interest in mitigation measures.
Hospital acquired infections, which are also referred to as nosocomial infections, can affect a patient during prolonged hospital stays. The occurrence of HAIs can be put down to the absence of the right kind of hospital infrastructure, lack of enough sensitization to pathogen transmission and hospitals not diligently following stipulated infection control practices.
Fastest growth within the global HAIs control market will be seen in the cleaning and sterilization segment. The report also observes that there will be considerable demand for HAIs control equipment in treating primary bloodstream infections.
The report notes that North America holds the largest share in the global HAIs control market essentially because the advanced healthcare facilities that exist here. The HAIs control market in North America stood at US$ 21,319.2 million in 2014 and is forecast to rise to US$ 34,430.3 million by the end of 2020, registering a CAGR of 8.3%. Among other crucial findings of the report is this: Asia Pacific will exhibit the fastest growth among all regions through the forecast period of the report, largely because of the growing pervasiveness of HAIs here.
Chapter 1 Preface

1.1 Report Description
1.2 Research Methodology
1.3 Assumptions

Send An Enquiry : http://www.mrrse.com/enquiry/116

Chapter 2 Market Synopsis
Chapter 3 Porter’s Five Forces Analysis

3.1 Bargaining Power of Suppliers
3.2 Bargaining Power of Buyers
3.3 Threat of New Entrants
3.4 Threat of Substitutes
3.5 Intensity of Rivalry

Chapter 4 Market Overview

4.1 Market Definition
4.2 Market Drivers
4.2.1 High prevalence of various hospital infections
4.2.2 Increasing aging population
4.2.3 Rising number of initiatives undertaken by government and nongovernment organizations
4.2.4 Hot and humid environmental conditions

4.3 Impact Analysis of Market Drivers

4.4 Market Restrains
4.4.1 Lack of primary healthcare facilities and infrastructure
4.4.2 Limited awareness about HAIs in developing regions

4.5 Impact Analysis of Market Restrains

4.6 Market Trends
4.6.1 Increasing popularity of gas plasma sterilization technology
4.6.2 Companies focusing on new product launches
4.6.3 Increasing number of mergers and acquisitions

4.7 Market Challenges
4.7.1 Rising number of multi-drug-resistant microbial pathogens

Chapter 5 Global Market Size and Forecast

5.1 On the Basis of Geography

5.2 On the Basis of Type
5.3 On the Basis of Diseases

Chapter 6 Market Size and Forecast by Cleaning and Sterilization

6.1 By Region

6.2 By Type
6.2.1 Instrument sterilization
6.2.2 Wide-area sterilization
6.2.3 Disinfection of linen

Chapter 7 Market Size and Forecast by Diagnostic Techniques

7.1 By Region

7.2 By Type
7.2.1 Manual testing
7.2.2 Automated testing
7.2.3 Confirmation testing

Chapter 8 Market Size and Forecast by Treatment

8.1 By Region

8.2 By Type
8.2.1 Pharmaceutical treatment
8.2.2 Environmental treatment

8.3 By Type of Pharmaceutical Treatment
8.3.1 Viral HAI pharmaceuticals
8.3.2 Bacterial HAI pharmaceuticals
8.3.3 Fungal HAI pharmaceuticals

8.4 By Type of Environmental Treatment
8.4.1 Air treatment
8.4.2 Water treatment
8.4.3 Chemical treatment

Chapter 9 Market Size and Forecast by Disease

9.1 Pneumonia
9.2 Gastrointestinal Illnesses
9.3 Urinary Tract Infections (UTI)
9.4 Surgical Site Infections
9.5 Primary Bloodstream Infections
Chapter 10 Market Size and Forecast by Geography

10.1 North America
10.2 Europe
10.3 Asia

Chapter 11 Competitive Scenario

11.1 Competitive Benchmarking
11.2 Company Share Analysis

Chapter 12 Company Profiles

12.1 Advanced Sterilization Products Division Ethicon US, LLC
12.1.1 Company overview
12.1.2 Products and services
12.1.3 Financial performance
12.1.4 Key developments

12.2 STERIS Corporation
12.2.1 Company overview
12.2.2 Product and segments
12.2.3 Financial performance
12.2.4 Key developments

12.3 Cepheid
12.3.1 Company overview
12.3.2 Products and services
12.3.3 Financial performance
12.3.4 Key developments

12.4 Cantel Medical
12.4.1 Company overview
12.4.2 Products and services
12.4.3 Financial performance
12.4.4 Key developments
12.5 Getinge AB
12.5.1 Company overview
12.5.2 Products and services
12.5.3 Financial performance
12.5.4 Key developments

12.6 Pfizer, Inc.
12.6.1 Company overview
12.6.2 Products and services
12.6.3 Financial performance
12.6.4 Key developments

12.7 Merck & Co., Inc.
12.7.1 Company overview
12.7.2 Products and services
12.7.3 Financial performance
12.7.4 Key developments

12.8 Hoffmann-La Roche, Ltd.
12.8.1 Company overview
12.8.2 Products and services
12.8.3 Financial performance
12.8.4 Key developments

12.9 Becton, Dickinson and Company
12.9.1 Company overview
12.9.2 Products and services
12.9.3 Financial performance
12.9.4 Key developments

12.10 Kimberly-Clark Corporation
12.10.1 Company overview
12.10.2 Products and services
12.10.3 Financial performance
12.10.4 Key developments

12.11 bioMerieux SA
12.11.1 Company overview
12.11.2 Products and services
12.11.3 Financial performance
12.11.4 Key developments


About Us
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. Headquartered in New York, U.S., MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


Contact Us:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Email: [email protected]
Website: http://www.mrrse.com/
Blog: http://mrrse.blogspot.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By mrrse
Website market research reports search engine
Phone 15186181030
Business Address State Tower 90, State Street Suite 700
Country United States
Categories Biotech , Health
Tags hospital acquired infections hais control
Last Updated May 25, 2015